Clinical Trial Update: Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating trilaciclib in combination with concurrent chemoradiotherapy and immunotherapy for esophageal cancer; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• trilaciclib (trilaciclib)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING